Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. (2020). Farmeconomia. Health Economics and Therapeutic Pathways, 21(1). https://doi.org/10.7175/fe.v21i1.1450